April 23, 2007 — Using actual US practice patterns and dosing, epoetin alfa (Epogen; peg-EPO therapy) effectively maintains hemoglobin (Hb) levels in hemodialysis patients, according to a presentation ...
Credit: Shutterstock Newly released safety data also show that roxadustat is associated with reduced cardiovascular risks compared with epoetin alfa. WASHINGTON—Roxadustat is superior to epoetin alfa ...
Value of caregiver ratings in evaluating the quality of life of patients with cancer. More than 500 community-based oncologists enrolled 2,342 patients with malignancies undergoing cytotoxic ...
Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Data presented here from the ROCKIES phase 3 trial showed use of the investigational ...
Dec. 9, 2004 -- The U.S. Food and Drug Administration (FDA) and Ortho Biotech Products warned healthcare professionals via letter of important information regarding the safe dosing of epoetin alfa ...
Breast cancer patients (N = 354) receiving chemotherapy were randomly assigned in 1:1 ratio to epoetin alfa (40,000 U qw) or standard of care (SOC). QOL was assessed at baseline and week 12.
Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Compared to epoetin alfa, roxadustat was more effective in raising hemoglobin levels and used less ...
Among over 300 patients who required red blood cell transfusions for anemia, 58.5% of those who received luspatercept achieved transfusion independence with hemoglobin increase versus 31.2% of those ...
In a phase 3 study, the mean hemoglobin change from baseline to average was significantly higher among roxadustat-treated patients compared with epoetin alfa recipients, according to investigators.
In people with myelodysplastic neoplasms (MDS), a usually benign form of chronic lymphocytic leukemia, the body produces too few functional blood cells. Affected individuals suffer from anemia—a lack ...
SAN FRANCISCO (MarketWatch) -- Amgen Inc. said late Thursday a Phase III study has demonstrated that Aranesp dosed every two weeks resulted in similar clinical efficacy as Epoetin alfa dosed once a ...
Epoetin alfa refers to erythropoietin (EPO), a hormone-like substance secreted by kidney and liver that stimulates erythropoiesis. Indications of EOP approved in China are renal anemia, anemia after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results